In a groundbreaking move for early detection and prevention of breast cancer, MedicalNet Co., Ltd. and its newly integrated subsidiary, Mirtel Inc., headquartered in Hiroshima, have unveiled an innovative e-commerce platform for the saliva-based breast cancer risk assessment test, "ScanTest Breast Cancer." This launch marks a significant step in making cancer screening more accessible and convenient, potentially leading to earlier diagnosis and treatment.
The Emergence of Accessible Screening
Breast cancer remains a formidable health challenge worldwide, with early detection being crucial for effective treatment and outcomes. Despite the advancements in medical technology, many individuals miss out on screening opportunities due to various barriers. Recognizing this gap, Mirtel Inc. developed the ScanTest Breast Cancer, a non-invasive saliva test that aims to simplify and encourage the screening process.
Simplifying Screening via LINE
The newly launched platform leverages LINE, a popular messaging app, to facilitate the entire process from purchasing the test kit to receiving results. This approach eliminates the need for downloading additional apps, making the process stress-free and user-friendly. Beyond just an e-commerce site, the platform offers comprehensive support including detailed explanations of the service, Q&A, and customer inquiries, ensuring users are well-informed and supported throughout their testing journey.
ScanTest Breast Cancer: A Closer Look
The ScanTest Breast Cancer is designed to detect changes in the balance of saliva metabolites that occur in breast cancer patients, aiding in the early detection of the disease. It offers a gentle testing method for those concerned about breast cancer but hesitant to undergo traditional screenings. While not a definitive diagnosis tool, the test serves as a supportive measure for early detection, urging individuals with high-risk results to seek further medical consultation.
MedicalNet Co., Ltd.: Mission and Services
MedicalNet aims to enhance health and quality of life through internet-based medical and lifestyle information services. With a focus on the dental medical field, the company provides a comprehensive range of services including information for dental patients and professionals, management support for dental clinics, and marketing support for dental-related businesses. Through these efforts, MedicalNet contributes to increasing smiles and improving health outcomes.
Mirtel Inc.: Vision and Impact
Founded as a startup from Hiroshima University in 2012, Mirtel Inc. is dedicated to "visualizing" unseen health and disease through liquid biopsy and data science. As a science solution provider, Mirtel's mission is to alleviate health and disease-related anxieties and hopes with science, aiming to bring smiles to people's faces globally.
For more information on the ScanTest Breast Cancer and other services provided by Mirtel Inc., interested parties can contact the company(https://www.mirtel.co.jp/2c-bc-scantest/) directly via phone or email.
Comments